Division of Oncology
in the Department of Medicine
Welcome to the Division of Oncology, a center of excellence in patient care, medical education, and state-of-the-art research. Cancer is a major public health problem and it is also an exciting challenge for discovery and innovation.
Message from the Chief
A welcome message from the the Division of Oncology's chief, Dr. George W. Sledge Jr.
The Division of Oncology is seeking qualified faculty for several open positions. Successful applicants must hold an MD or MD/PhD degree and be board-certified or board-eligible in Medical Oncology, and have a history of significant peer-reviewed funding.
- To engage in research to create the future of cancer care
- To provide the best in care for cancer patients
- To train physicians for careers in academic medicine and research
IN THE NEWS
- Watch NBC for an update on Dr. Ronald Levy's upcoming cancer vaccine study
- Listen to Science Friday for an interview about the Levy lab's cancer vaccine discovery published in Science Translational Medicine on 1/31/18
- During a recent TedxPaloAlto talk, Idit Sagiv-Barfi, MD, PHD, an instructor of oncology, discussed the future of cancer vaccines.
- OncLive® recognizes Dr. Saul Rosenberg as a 2019 Giant of Cancer Care for his work in lymphoma. Winners will be celebrated at the seventh annual reception in Chicago on May 30. Read more here.
It is our pleasure to introduce several new faculty members in the Division of Oncology
Dr. Curtis Chong is a new Assistant Professor in our Clinician Educator line. Curtis joins us from Memorial Sloan Kettering, having completed his Hematology/Oncology fellowship at Dana-Farber Cancer Institute in 2015. While part of the Memorial system he participated actively in their Phase I program. Here he will be splitting his time between our Phase I group and Redwood City, where he will serve as a general medical oncologist in the UHA group there. We’re delighted to have him join our ranks.
Dr. Fauzia Riaz is a new Clinical Assistant Professor in Breast Oncology. Fauzia joins us from Yale, where she completed her Hematology/Oncology fellowship this year. Previous to this she did her Internal Medicine residency at Georgetown, where she served as Chief Resident. Fauzia has joined us as a member of the Breast Oncology in the Women’s Cancer Center, involved in both patient care and clinical research. She has a strong interest in palliative care. We are happy to welcome Fauzia to Stanford.
Dr. Shagufta Shaheen also joins the Oncology division as a Clinical Assistant Professor. Many of you will remember Shagufta from her just-completed advanced fellowship training in Neuroendocrine Tumors here at Stanford, the first program of its kind in the US. Prior to that, she completed a Hematology/Oncology fellowship at Loma Linda. She will split her outpatient clinic time between the GI group and Neuroendocrine group, and will support our inpatient oncology work. Of interest, Shagufta served as a hospitalist at Massachusetts General Hospital prior to her oncology fellowship, and we hope to make use of this experience in strengthening our inpatient service. We’re delighted to have her.